Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease
- 26 April 2010
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 67 (4), 462-469
- https://doi.org/10.1002/ana.21910
Abstract
Objective Olfactory dysfunction is common in Alzheimer disease (AD) and other neurodegenerative diseases. Paired helical filament (PHF)‐tau, α‐synuclein, and amyloid‐β lesions occur early and severely in cerebral regions of the olfactory system, and they have also been observed in olfactory epithelium (OE). However, their frequency, abundance, and disease specificity, and the relationships of OE pathology to brain pathology have not been established. Methods We investigated the pathological expression of amyloid‐β, PHFtau, α‐synuclein, and TDP‐43 in postmortem OE of 79 cases with AD, 63 cases with various other neurodegenerative diseases, and 45 neuropathologically normal cases. Results Amyloid‐β was present as punctate and small patchy aggregates in 71% of AD cases, compared with 22% of normal cases and 14% of cases with other diseases, and in greater amounts in AD than in either of the other 2 diagnostic categories. PHFtau was evident in dystrophic neurites in 55% of cases with AD, 34% with normal brains, and 39% with other neurodegenerative diseases, also at higher densities in AD. α‐Synuclein was present in dystrophic neurites in 7 cases, 6 of which also had cerebral Lewy bodies. Pathological TDP‐43 inclusions were not observed in the OE in any cases. Amyloid‐β and to a lesser degree, PHFtau ratings in OE significantly correlated with cortical Aβ and PHFtau lesion ratings in the brain. Interpretation These data demonstrate that AD pathology in the OE is present in the majority of cases with pathologically verified AD and correlates with brain pathology. Future work may assess the utility of amyloid‐β and PHFtau measurement in OE as a biomarker for AD. ANN NEUROL 2010;67:462–469This publication has 68 references indexed in Scilit:
- Odor quality coding and categorization in human posterior piriform cortexNature Neuroscience, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathiesActa Neuropathologica, 2009
- Olfactory Function in Corticobasal Syndrome and Frontotemporal DementiaArchives of Neurology, 2009
- The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferationCurrent Opinion in Neurology, 2008
- Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's DiseaseThe American Journal of Pathology, 2008
- Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathologica, 2008
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationActa Neuropathologica, 2007
- The relationship between cerebral Alzheimer's disease pathology and odour identification in old ageJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991